| Literature DB >> 28860778 |
Camila Miliani Capelini1, Talita Dias da Silva2, James Tonks3,4,5, Suzanna Watson6, Mayra Priscila Boscolo Alvarez1, Lilian Del Ciello de Menezes1, Francis Meire Favero2, Fátima Aparecida Caromano1, Thais Massetti1, Carlos Bandeira de Mello Monteiro1.
Abstract
BACKGROUND: In individuals severely affected with Duchenne muscular dystrophy (DMD), virtual reality has recently been used as a tool to enhance community interaction. Smartphones offer the exciting potential to improve communication, access, and participation, and present the unique opportunity to directly deliver functionality to people with disabilities.Entities:
Keywords: cell phone; motor skills; physical therapy; transfer of learning; virtual reality exposure therapy
Year: 2017 PMID: 28860778 PMCID: PMC5571857 DOI: 10.2147/NDT.S125466
Source DB: PubMed Journal: Neuropsychiatr Dis Treat ISSN: 1176-6328 Impact factor: 2.570
Figure 1Study casuistic and composition of groups.
Notes: TD: group with TD; DMD: group with DMD.
Abbreviations: DMD, Duchenne muscular dystrophy; TD, typical development.
Characterization of the sample (mean ± SD)
| Variables | TD
| DMD
| |||
|---|---|---|---|---|---|
| TD1 | TD2 | DMD1 | DMD2 | ||
| Age (years) | 17.1±4.3 | 17.4±4.4 | 17.1±5.3 | 17.2±4.7 | 0.475 |
| MFM-total (%) | – | – | 49.7±17.7 | 47.2±20.8 | 0.413 |
| MFM-D1 (%) | – | – | 11.4±19.9 | 14.3±24.2 | 0.244 |
| MFM-D2 (%) | – | – | 67.8±26.7 | 64.2±27.4 | 0.319 |
| MFM-D3 (%) | – | – | 79.0±17.9 | 80.7±13.2 | 0.328 |
| EK scale | – | – | 8.6±6.3 | 8.6±6.2 | 0.435 |
| Vignos | – | – | 6.4±2.3 | 6.3±2.2 | 0.441 |
Notes: For differences between DMD groups, Student’s t-test was performed (P<0.05). TD: group with TD (matched for age with DMD group); DMD: group with DMD. MFM-D1, D2, and D3 indicate scores in the first, second, and third domains of MFM scale, respectively.
Abbreviations: DMD, Duchenne muscular dystrophy; EK, Egen Klassifikation; MFM, Motor Function Measure; SD, standard deviation; TD, typical development.
Figure 2Labyrinths used for the stages of acquisition, short-term retention, and transfer.
Notes: Maze A: used in acquisition and in transfer 2 for groups DMD1 and TD1 and in transfer 1 for groups DMD2 and TD2; Maze B: used in acquisition and transfer 2 for groups DMD2 and TD2 and in transfer 1 for groups DMD1 and TD1; Maze C = used in transfer 3 of groups DMD1 and TD1; Maze D = used in transfer 3 of groups DMD2 and TD2.
Abbreviations: DMD, Duchenne muscular dystrophy; TD, typical development.
Experimental design of motor learning protocol
| Groups | Acquisition | Short-term retention | Transfer 1 | Transfer 2 | Transfer 3 |
|---|---|---|---|---|---|
| DMD1 | Maze A | Maze A | Maze B | Maze A | Maze C |
| TD1 | (30 trials) | (5 trials) | (5 trials) | Nondominant hand (5 trials) | Start/end inverted (5 trials) |
| DMD2 | Maze B | Maze B | Maze A | Maze B | Maze D |
| TD2 | (30 trials) | (5 trials) | (5 trials) | Nondominant hand (5 trials) | Start/end inverted (5 trials) |
Notes: TD: group with TD; DMD: group with DMD.
Abbreviations: DMD, Duchenne muscular dystrophy; TD, typical development.
Figure 3Graphical representation of the means and standard errors of the blocks of trials in TD and DMD groups.
Notes: Each block refers to a set of five trials. A1–A6: blocks of acquisition phase; R: block of short-term retention test; T1: block of transfer with opposite maze; T2: block of transfer with nondominant hand; T3: block of transfer with exchange start–final. Groups that performed maze A on acquisition: DMD1 and TD1. Groups that performed maze B in acquisition: DMD2 and TD2.
Abbreviations: DMD, Duchenne muscular dystrophy; TD, typical development.